{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:42:45Z","timestamp":1786718565646,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Androl"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/aja.aja_71_17","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T04:34:05Z","timestamp":1517891645000},"page":"107","source":"Crossref","is-referenced-by-count":2,"title":["Why is understanding the relationship of testosterone to cardiovascular risk so important?"],"prefix":"10.4103","volume":"20","author":[{"given":"BuB","family":"Yeap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BradleyD","family":"Anawalt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1008-682X.224772-1","first-page":"168\u201382","volume-title":"Do low testosterone levels contribute to ill-health during male ageing?","author":"Yeap","year":"2012","journal-title":"Crit Rev Clin Lab Sci"},{"key":"key-10.4103\/1008-682X.224772-2","first-page":"943\u201356","volume-title":"Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews","author":"Onasanya","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"key-10.4103\/1008-682X.224772-3","first-page":"967","volume-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.JAMA 2013; 310: 1829\u201336","author":"Vigen","year":"2014","journal-title":"Erratum published in JAMA"},{"key":"key-10.4103\/1008-682X.224772-4","first-page":"2706\u201315","volume-title":"Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men","author":"Sharma","year":"2015","journal-title":"Eur Heart J"},{"key":"key-10.4103\/1008-682X.224772-5","first-page":"491\u20139","volume-title":"Association of testosterone replacement with cardiovascular outcomes among men with androgen deficiency","author":"Cheetham","year":"2017","journal-title":"JAMA Intern Med"},{"key":"key-10.4103\/1008-682X.224772-6","first-page":"611\u201324","volume-title":"Effects of testosterone treatment in older men","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1008-682X.224772-7","first-page":"717\u201327","volume-title":"Testosterone treatment and cognitive function in older men with low testosterone and age-associated memory impairment","author":"Resnick","year":"2017","journal-title":"JAMA"},{"key":"key-10.4103\/1008-682X.224772-8","first-page":"471\u20139","volume-title":"Effect of testosterone treatment on volumetric bone density and strength in older men with low testosterone: a controlled clinical trial","author":"Snyder","year":"2017","journal-title":"JAMA Intern Med"},{"key":"key-10.4103\/1008-682X.224772-9","first-page":"480\u201390","volume-title":"Association of testosterone levels with anemia in older men: a controlled clinical trial","author":"Roy","year":"2017","journal-title":"JAMA Intern Med"},{"key":"key-10.4103\/1008-682X.224772-10","first-page":"708\u201316","volume-title":"Testosterone treatment and coronary artery plaque volume in older men with low testosterone","author":"Budoff","year":"2017","journal-title":"JAMA"},{"key":"key-10.4103\/1008-682X.224772-11","first-page":"173\u20138","volume-title":"Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy","author":"Yeap","year":"2016","journal-title":"Med J Aust"},{"key":"key-10.4103\/1008-682X.224772-12","first-page":"228\u201331","volume-title":"Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations","author":"Yeap","year":"2016","journal-title":"Med J Aust"},{"key":"key-10.4103\/1008-682X.224772-13","first-page":"548\u201351","volume-title":"Global trends in testosterone prescribing, 2000\u20132011: expanding the spectrum of prescription drug misuse","author":"Handelsman","year":"2013","journal-title":"Med J Aust"},{"key":"key-10.4103\/1008-682X.224772-14","first-page":"835\u201342","volume-title":"Testosterone lab testing and initiation in the United Kingdom and the United States 2000\u20132011","author":"Layton","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1008-682X.224772-15","first-page":"2032\u20134","volume-title":"Clinical decisions: testosterone-replacement therapy","author":"Swerdloff","year":"2014","journal-title":"New Engl J Med"},{"key":"key-10.4103\/1008-682X.224772-16","first-page":"109\u201314","volume-title":"Testosterone and its metabolites: differential associations with cardiovascular and cerebrovascular events in men","author":"Yeap","year":"2018","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.224772-17","first-page":"115\u20139","volume-title":"Endogenous testosterone and mortality risk","author":"Meyer","year":"2018","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.224772-18","first-page":"120\u201330","volume-title":"Randomized controlled trials \u2013 mechanistic studies of testosterone and the cardiovascular system","author":"Jones","year":"2018","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.224772-19","first-page":"131\u20137","volume-title":"Trials of testosterone replacement reporting cardiovascular adverse events","author":"Gagliano-Juca","year":"2018","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.224772-20","first-page":"138\u201344","volume-title":"Testosterone treatment and cardiovascular events in analyses of prescription databases","author":"Shores","year":"2018","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.224772-21","first-page":"149\u201351","volume-title":"Testosterone replacement therapy: dilemmas and challenges in China and Asia","author":"An","year":"2018","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.224772-22","first-page":"145\u20138","volume-title":"Would male hormonal contraceptives affect cardiovascular risk?","author":"Zitzmann","year":"2018","journal-title":"Asian J Androl"}],"container-title":["Asian Journal of Andrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:36:45Z","timestamp":1786714605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aja.aja_71_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"alternative-id":["224772"],"URL":"https:\/\/doi.org\/10.4103\/aja.aja_71_17","relation":{},"ISSN":["1008-682X"],"issn-type":[{"value":"1008-682X","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}